Silk Road Medical (NASDAQ:SILK) Downgraded by Zacks Investment Research to Hold

Silk Road Medical} stock has undergone multiple analysts rating changes in the recent past.  Silk Road Medical Downgraded by Zacks Investment Research on 10/30/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Buy.

View More Silk Road Medical (NASDAQ:SILK) Downgraded by Zacks Investment Research to Hold

Reports Strong First-Quarter Financial Results NASDAQ:BFST, NASDAQ:YNDX, NASDAQ:FUSB, NASDAQ:SILK

Quarterly, annual earnings. See the latest EPS estimates vs Actual and surprise it caused. Stock Market Daily has their analysis…

View More Reports Strong First-Quarter Financial Results NASDAQ:BFST, NASDAQ:YNDX, NASDAQ:FUSB, NASDAQ:SILK

Earnings and Growth Analysis : Silk Road Medical (NASDAQ:SILK)

Earnings results for Silk Road Medical , Analyst Opinion on Silk Road Medical , Earnings and Valuation of (NASDAQ:SILK), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Earnings and Growth Analysis : Silk Road Medical (NASDAQ:SILK)

Does Earnings Surprise History Hold Any Clue for Silk Road Medical (NASDAQ:SILK)

Earnings results for Silk Road Medical , Analyst Opinion on Silk Road Medical , Earnings and Valuation of (NASDAQ:SILK), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Does Earnings Surprise History Hold Any Clue for Silk Road Medical (NASDAQ:SILK)

Analyst Valuation and EPS Growth for Silk Road Medical (NASDAQ:SILK)

Earnings results for Silk Road Medical , Analyst Opinion on Silk Road Medical , Earnings and Valuation of (NASDAQ:SILK), Stock market Insights & financial analysis, Best stock to invest, Investment Idea,

View More Analyst Valuation and EPS Growth for Silk Road Medical (NASDAQ:SILK)